Your browser doesn't support javascript.
loading
Chlorogenic acid protects against myocardial ischemia-reperfusion injury in mice by inhibiting Lnc Neat1/NLRP3 inflammasome-mediated pyroptosis.
Chai, Xin; Liang, Zhengwei; Zhang, Junshi; Ding, Jing; Zhang, Qian; Lv, Sha; Deng, Yazhu; Zhang, Rongrui; Lu, Deqin.
Afiliação
  • Chai X; Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
  • Liang Z; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, 550025, China.
  • Zhang J; Department of Pathophysiology, Guizhou Medical University, Guiyang, China.
  • Ding J; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, 550025, China.
  • Zhang Q; Department of Pathophysiology, Guizhou Medical University, Guiyang, China.
  • Lv S; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, 550025, China.
  • Deng Y; Department of Pathophysiology, Guizhou Medical University, Guiyang, China.
  • Zhang R; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, 550025, China.
  • Lu D; Department of Pathophysiology, Guizhou Medical University, Guiyang, China.
Sci Rep ; 13(1): 17803, 2023 10 18.
Article em En | MEDLINE | ID: mdl-37853132

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Inflamassomos Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Inflamassomos Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article